Gene · 8321
Papers2,162
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,162
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Mechanism of Wnt Pathway Regulated by Telocytes to Promote the Regeneration and Repair of Intrauterine Adhesions. | Comput Math Methods Med | 2022 | 35844454 | PubTator, text mining | PubMed |
| Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. | Mol Cancer | 2022 | 35836256 | PubTator, text mining | PubMed |
| Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients. | Sci Rep | 2022 | 35835840 | PubTator, text mining | PubMed |
| Gait analysis dataset of healthy volunteers and patients before and 6 months after total hip arthroplasty. | Sci Data | 2022 | 35821499 | PubTator, text mining | PubMed |
| Receptor control by membrane-tethered ubiquitin ligases in development and tissue homeostasis. | Curr Top Dev Biol | 2022 | 35817504 | PubTator, text mining | PubMed |
| Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer. | Front Pharmacol | 2022 | 35814205 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer. | J Biol Chem | 2022 | 35810788 | PubTator, text mining | PubMed |
| Breast Cancer Stem Cells: Signaling Pathways, Cellular Interactions, and Therapeutic Implications. | Cancers (Basel) | 2022 | 35805056 | PubTator, text mining | PubMed |
| Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer. | Cancers (Basel) | 2022 | 35804965 | PubTator, text mining | PubMed |
| Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer. | J Immunol Res | 2022 | 35800989 | PubTator, text mining | PubMed |
| Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting. | Stem Cells Int | 2022 | 35800881 | PubTator, text mining | PubMed |
| Progress and application of epitranscriptomic m6A modification in gastric cancer. | RNA Biol | 2022 | 35796515 | PubTator, text mining | PubMed |
| SFRP1 Negatively Modulates Pyroptosis of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis: A Review. | Front Immunol | 2022 | 35795672 | PubTator, text mining | PubMed |
| Human Borna disease virus 1 encephalitis shows marked pro-inflammatory biomarker and tissue immunoactivation during the course of disease. | Emerg Microbes Infect | 2022 | 35788177 | PubTator, text mining | PubMed |
| The Role of Lipid Metabolism in Gastric Cancer. | Front Oncol | 2022 | 35785165 | PubTator, text mining | PubMed |
| Effects of Triiodothyronine on Human Osteoblast-Like Cells: Novel Insights From a Global Transcriptome Analysis. | Front Cell Dev Biol | 2022 | 35784485 | PubTator, text mining | PubMed |
| The SKBR3 cell-membrane proteome reveals telltales of aberrant cancer cell proliferation and targets for precision medicine applications. | Sci Rep | 2022 | 35760832 | PubTator, text mining | PubMed |
| Targeting signaling pathways in prostate cancer: mechanisms and clinical trials. | Signal Transduct Target Ther | 2022 | 35750683 | PubTator, text mining | PubMed |
| A dual-activity topoisomerase complex regulates mRNA translation and turnover. | Nucleic Acids Res | 2022 | 35748872 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8321/papers?page=18